Based on the 2 registry cases, the prevalence of pathogenic UBA1 mutations was 0.18% among MDS patients (2 of 1139) and 0.38% among male MDS patients over 45 years of age (2 of 525). The gene discussed is UBA1; the disease is myelodysplastic syndrome.